Energy restriction as an antitumor target of thiazolidinediones.
about
Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agentDisruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formationEnergy sensing pathways: Bridging type 2 diabetes and colorectal cancer?Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.Prospects on strategies for therapeutically targeting oncogenic regulatory factors by small-molecule agentsEnergy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death.2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.Development of a novel class of glucose transporter inhibitors.A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibition.Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier.Pioglitazone acutely reduces energy metabolism and insulin secretion in ratsSuppression of prostate epithelial proliferation and intraprostatic progrowth signaling in transgenic mice by a new energy restriction-mimetic agent.Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.Enzymatic features of the glucose metabolism in tumor cells.Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis.Regulation of pyruvate metabolism in metabolic-related diseases.Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance.OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro.PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.Potential targets of energy restriction mimetic agents in cancer cells.Energy restriction: stepping stones towards cancer therapy.Energy restriction as an antitumor target.
P2860
Q28484382-A73441F7-8894-4E02-A720-2A024CAB00FCQ28588760-DCD5D39E-87B1-429D-9403-C4AADB919F4CQ30234587-7AA8AF0D-73F3-472E-A783-069B2A765A20Q34054119-EC94048E-F433-4548-8C3F-37FD67B7B4EAQ34260205-50C35C51-74B2-403B-A3E7-948D139A030AQ34554617-C3A320DD-03D6-4516-B3DB-AC958BA6DEA3Q34696245-14D80D4E-5012-42E2-8D94-A2158DB2E440Q34771531-92F1FE49-32D4-4911-825E-48FEC0EFC9F4Q34977236-00761A41-8B04-40D3-9B79-55B910283101Q35954892-4DC57F5B-107B-4C12-AFD9-6E938C849886Q36032683-660A8976-7F2A-46A9-BBA9-0568047C63FEQ36238466-E52DD4EB-B026-45EA-A888-5787EEDC2459Q36481823-FAE204A7-FCD9-46B2-8C08-0F477299A0A8Q36747796-0A3E2F70-C846-48DA-B857-FB7ADAE8802AQ36867430-A98EEC37-A45C-4B58-9542-C145B0BAA035Q37328622-DD77426B-F3D3-4798-9659-A6FFB2D7C27FQ37354557-75ED1134-857B-421C-BB2B-9D0479EE0485Q37403008-8E02465C-304A-4644-814A-E0AAC601E25CQ37874709-92816AD8-1DB6-4134-A18D-22D30237BD69Q38082724-9E20CEDB-A9FD-4E9A-B31E-31B6079BCE37Q38161453-4041616E-3FEB-4CE8-91EB-58054215608AQ38181145-E85A9442-469B-4CB5-A418-4CD53FBB56D7Q39624446-59131124-6CEE-4C36-907B-E2EC852FB5C3Q43170996-A4C98657-BA53-4191-B507-1E6A9C7D4791Q45797168-E35EDB15-5FC5-4FF3-A71D-989CE9556F0EQ46890228-1AEE72EF-0D86-480D-94BE-F6CBB4D848B7Q51532832-9C0725A8-59F0-466A-AA3A-61E5C7E87E41Q51773654-BD282193-631F-4D86-AB85-40C7EE3C971E
P2860
Energy restriction as an antitumor target of thiazolidinediones.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Energy restriction as an antitumor target of thiazolidinediones.
@ast
Energy restriction as an antitumor target of thiazolidinediones.
@en
type
label
Energy restriction as an antitumor target of thiazolidinediones.
@ast
Energy restriction as an antitumor target of thiazolidinediones.
@en
prefLabel
Energy restriction as an antitumor target of thiazolidinediones.
@ast
Energy restriction as an antitumor target of thiazolidinediones.
@en
P2093
P2860
P356
P1476
Energy restriction as an antitumor target of thiazolidinediones.
@en
P2093
Ching-Shih Chen
Samuel K Kulp
P2860
P304
P356
10.1074/JBC.M109.065466
P407
P577
2010-01-21T00:00:00Z